# MassBiologics, Boston, MA – FDA Inspections

Source: https://www.keypedia.com/companies/massbiologics/fa584e7c-22de-470c-836a-dd3028fae600

> Inspection records and compliance data for MassBiologics in Boston, Massachusetts. 7 FDA inspections on record, 2 Form 483s, last inspected December 18, 2025.

---

## Details

- Name: MassBiologics
- FEI Number: 3003058218
- Address Line 1: 460 Walk Hill St
- City: Boston
- State: Massachusetts
- Zip Code: 02126
- Country Name: United States
- Address: 460 Walk Hill St, Boston, Massachusetts 02126, United States
- Country: United States

## Related Documents

- [483 - MassBiologics - Unknown Date](https://www.keypedia.com/records/483/massbiologics/55d58639-f609-454b-a2a1-0c03a56ff9df) — source: FDA, date: Invalid Date
- [483 - MassBiologics - 2025-12-18](https://www.keypedia.com/records/483/massbiologics/32cddc50-58d8-43da-866b-326888199b33) — source: FDA, date: December 18, 2025
- [FDA Inspection 1295884 - MassBiologics - 2025-12-18](https://www.keypedia.com/records/fda_inspections/massbiologics/59145ac7-9432-45dd-a9f2-8261c7a7bc98) — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 18, 2025
- [483 - MassBiologics - 2022-09-01](https://www.keypedia.com/records/483/massbiologics/7697ffb3-e3e5-4b7c-b35f-71dbfed07048) — source: FDA, date: September 1, 2022
- FDA Inspection 1180878 - MassBiologics - 2022-09-01 — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 1, 2022
- [483 - MassBiologics - 2019-11-19](https://www.keypedia.com/records/483/massbiologics/24eda3f4-f224-42fc-9272-a6f151517450) — source: FDA, date: November 19, 2019
- FDA Inspection 1110938 - MassBiologics - 2019-11-19 — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 19, 2019
- [FDA Inspection 1008977 - MassBiologics - 2017-03-09](https://www.keypedia.com/records/fda_inspections/massbiologics/5cf9f83e-8ad2-4761-8d4b-4fcfa45a3cd7) — source: FDA, date: March 9, 2017
- FDA Inspection 878428 - MassBiologics - 2014-05-20 — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 20, 2014
- FDA Inspection 787420 - MassBiologics - 2012-05-24 — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 24, 2012
- FDA Inspection 674186 - MassBiologics - 2010-07-21 — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 21, 2010
- [483 - MassBiologics - 2010-07-13](https://www.keypedia.com/records/483/massbiologics/0a149ddf-e774-426d-9cda-94a22372b436) — source: FDA, date: July 13, 2010

## Related Companies

- [Dendreon Pharmaceuticals LLC](https://www.keypedia.com/companies/dendreon-pharmaceuticals-llc/68ccd67e-0a3a-41cb-ae30-e9e10a6eaef5)
- [Takeda Pharmaceutical Company Limited](https://www.keypedia.com/companies/takeda-pharmaceutical-company-limited/4611dabc-52f7-4b4a-96bf-4196e34a7c2b)
- [Novartis Gene Therapies Inc.](https://www.keypedia.com/companies/novartis-gene-therapies-inc/23cc49c0-8794-437d-a2c2-4197479c5fb3)
- [Humacyte Global Inc](https://www.keypedia.com/companies/humacyte-global-inc/74158903-037d-4b32-a3b5-6c90f73f3f1f)
- [Kamada - Production Plant](https://www.keypedia.com/companies/kamada-production-plant/d3a7a962-b08c-4278-8951-5cad5bcfed41)
- [Roslin Cell Therapies Limited](https://www.keypedia.com/companies/roslin-cell-therapies-limited/284a8034-03ae-4031-906d-7603e297f7ab)
- [Autolus Limited](https://www.keypedia.com/companies/autolus-limited/1961ca64-40e0-44c3-a789-bc25ce1244c2)
- [Seqirus Inc](https://www.keypedia.com/companies/seqirus-inc/0debebe6-6f57-40d3-abf9-5914fb18b58a)
- [Regenerative Processing Plant, LLC](https://www.keypedia.com/companies/regenerative-processing-plant-llc/9460f9cb-85fa-400b-9e07-36e5b2a73133)
- [Kite Pharma, Inc.](https://www.keypedia.com/companies/kite-pharma-inc/5bf88060-db53-466b-9a1c-85be7984894f)

## Related Officers

- [Program Expert for Advanced Manufacturing ](https://www.keypedia.com/people/prabhu-p-raju/2c0aaede-fe16-4431-bc21-614d7f18cb32)
- [investigator](https://www.keypedia.com/people/susan-m-jackson/2a4e01d1-8761-4d40-b493-69a4163473bb)
- [James E. Keller](https://www.keypedia.com/people/james-e-keller/6d30d4b5-a97a-4825-bcf9-ee57c100eaee)
- [Executive Director](https://www.keypedia.com/people/janet-j-bowen/c7146abc-0842-4952-b9e1-7a9dbef2a35f)
- [Strategic Expert at NovoNordisk; Retired from FDA](https://www.keypedia.com/people/debra-m-emerson/58bd7fac-28eb-4369-b149-13a24cc00cf7)